These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9737327)

  • 21. Test purchase, identification and synthesis of 2-amino-1-(4-bromo-2, 5-dimethoxyphenyl)ethan-1-one (bk-2C-B).
    Power JD; Kavanagh P; O'Brien J; Barry M; Twamley B; Talbot B; Dowling G; Brandt SD
    Drug Test Anal; 2015 Jun; 7(6):512-8. PubMed ID: 25078895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of 4-bromo-2,5-dimethoxyphenethylamine abuser's urine: identification and quantitation of urinary metabolites.
    Kanamori T; Nagasawa K; Kuwayama K; Tsujikawa K; Iwata YT; Inoue H
    J Forensic Sci; 2013 Jan; 58(1):279-87. PubMed ID: 23066942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department.
    Sherlock K; Wolff K; Hay AW; Conner M
    J Accid Emerg Med; 1999 May; 16(3):194-7. PubMed ID: 10353046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Texture of Psychoactive Illicit Drugs in Iran: Adulteration with Lead and other Active Pharmaceutical Ingredients.
    Akhgari M; Moradi F; Ziarati P
    J Psychoactive Drugs; 2018; 50(5):451-459. PubMed ID: 30130472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and application of a high-performance liquid chromatography method using monolithic columns for the analysis of ecstasy tablets.
    Mc Fadden K; Gillespie J; Carney B; O'Driscoll D
    J Chromatogr A; 2006 Jul; 1120(1-2):54-60. PubMed ID: 16466734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impurity profiling of seized MDMA tablets by capillary gas chromatography.
    Palhol F; Boyer S; Naulet N; Chabrillat M
    Anal Bioanal Chem; 2002 Sep; 374(2):274-81. PubMed ID: 12324849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening experiments of ecstasy street samples using near infrared spectroscopy.
    Sondermann N; Kovar KA
    Forensic Sci Int; 1999 Dec; 106(3):147-56. PubMed ID: 10680063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological content of tablets sold as "ecstasy": results from an online testing service.
    Tanner-Smith EE
    Drug Alcohol Depend; 2006 Jul; 83(3):247-54. PubMed ID: 16364567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two immunoassays for the detection of 2C-B and related hallucinogenic phenethylamines.
    Šuláková A; Fojtíková L; Holubová B; Bártová K; Lapčík O; Kuchař M
    J Pharmacol Toxicol Methods; 2019; 95():36-46. PubMed ID: 30481558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes.
    Pasin D; Cawley A; Bidny S; Fu S
    Drug Test Anal; 2017 Oct; 9(10):1620-1629. PubMed ID: 28133938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A contribution to the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets.
    Gimeno P; Besacier F; Chaudron-Thozet H; Girard J; Lamotte A
    Forensic Sci Int; 2002 Jun; 127(1-2):1-44. PubMed ID: 12098525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethylamphetamine (ecstasy).
    Carter JF; Titterton aE; Murray M; Sleeman R
    Analyst; 2002 Jun; 127(6):830-3. PubMed ID: 12146919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of 3,4-methylenedioxyamphetamine analogs encountered in clandestine tablets.
    Furnari C; Ottaviano V; Rosati F; Tondi V
    Forensic Sci Int; 1998 Mar; 92(1):49-58. PubMed ID: 9627975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and identification of urinary metabolites of 4-iodo-2,5-dimethoxyphenethylamine.
    Kanamori T; Kuwayama K; Tsujikawa K; Miyaguchi H; Iwata YT; Inoue H
    J Forensic Sci; 2011 Sep; 56(5):1319-23. PubMed ID: 21595694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of an HPLC method for quantitation of MDMA in tablets.
    Müller IB; Windberg CN
    J Chromatogr Sci; 2005 Sep; 43(8):434-7. PubMed ID: 16212786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Composition profiling of seized ecstasy tablets by Raman spectroscopy.
    Bell SE; Burns DT; Dennis AC; Matchett LJ; Speers JS
    Analyst; 2000 Oct; 125(10):1811-5. PubMed ID: 11070550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is online information on ecstasy tablet content safe?
    Vrolijk RQ; Brunt TM; Vreeker A; Niesink RJ
    Addiction; 2017 Jan; 112(1):94-100. PubMed ID: 27518128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
    Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M
    Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determination of 4-bromo-2,5-dimethoxyamphetamine (DOB) found in illicit tablets seized in Italy].
    Furnari C; Ottaviano V; Rosati F
    Ann Ist Super Sanita; 2001; 37(2):297-300. PubMed ID: 11758288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of ecstasy tablets using capillary electrophoresis with capacitively coupled contactless conductivity detection.
    Porto SK; Nogueira T; Blanes L; Doble P; Sabino BD; do Lago CL; Angnes L
    J Forensic Sci; 2014 Nov; 59(6):1622-6. PubMed ID: 25039689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.